Section 424 - Statement of Commission's Intent, Application of Article, Definitions(a) It is the Commission's intent to allow a narrow exception to Regulation 303's prohibition against the Administration or use of Prohibited Substances and/or Prohibited Methods for those athletes who are medically required to use a Prohibited Substance or Prohibited Method. Such athletes may apply for a Therapeutic Use Exemption (TUE) only as provided by this Article. It is further the Commission's intent to ban all forms of Testosterone Replacement Therapy from use by athletes who are licensed by the Commission, except as expressly provided for in Commission Regulations, chapter 6.(b) This Article shall apply to all athletes who are licensed by the Commission or are participating in Commission-regulated events.(c) Definitions. As used in this Article, the following terms shall have the following meanings: (1) "Prohibited Substance" is defined in Commission Regulation 303.(2) "Prohibited Method" is defined in Commission Regulation 303.(3) "Testosterone Replacement Therapy" or "TRT" means the use of natural or synthetic testosterone to treat or replace testosterone deficiency in men.(4) "Board-certified physician" means a licensed doctor of medicine (M.D.) or osteopathy (O.D.), or a nurse practitioner or physician's assistant, in good standing and authorized to practice under state law, and practicing consistent with the laws governing their respective scope of practice in the state in which they are licensed.(5) "Acute medical condition" includes but is not limited to gender dysphoria and low testosterone resulting from testicular cancer or treatments for testicular cancer.Cal. Code Regs. Tit. 4, § 424
1. New article 12.5 (sections 424-426) and section filed 9-15-2016; operative 1-1-2017 (Register 2016, No. 38). Note: Authority cited: Section 18611, Business and Professions Code. Reference: Sections 18640, 18642, 18648, 18649, 18661 and 18711, Business and Professions Code.
1. New article 12.5 (sections 424-426) and section filed 9-15-2016; operative 1/1/2017 (Register 2016, No. 38).